Innovative hydrogenation process using Fe, Co, and Mn metal salts with cost-effective hydride sources to optimize hydrogenation of unsaturated triglycerides. Aimed at improving selectivity and efficiency for industrial applications.
The research proposes an innovative hydrogenation process utilizing benign metal salts such as Fe(acac)3, Co(acac)3, and Mn(acac)3 in combination with inexpensive hydride sources like sodium alkoxides, silanes, and metal hydrides. This process aims to optimize the hydrogenation of unsaturated triglycerides, which has significant implications for industries relying on natural oils. By employing a hydrogen atom transfer mechanism, the process promises enhanced selectivity and efficiency, making it a potentially transformative approach for industrial hydrogenation applications.
Currently, the technology is at TRL 2. The upcoming steps include determining the most effective combinations of metal salts and hydride sources for selective reduction of internal olefins. The focus will then shift to optimizing the most promising systems for potential commercialization over the next three years.
The University of Toronto is a comprehensive public research university with three campuses in the Toronto region and a globally scaled research enterprise. Its downtown footprint is embedded within a major academic health network and an adjacent innovation district, enabling co-located labs, clinical trials, and rapid testing with end users. Companies connect through co-op and long-duration internships, sponsored research, and access to shared core facilities and prototyping resources. Research is supported by Canada’s Tri‑Agency (NSERC, CIHR, SSHRC) and the Canada Foundation for Innovation, alongside provincial programs and industry partnerships. A dedicated technology transfer office provides IP management, licensing, and startup support through a coordinated entrepreneurship network.